2-(Cyclohexylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACRATN062
CAS No. :
1048111-37-0
Molecular Formula :
C14H23BO2
Molecular Weight :
234.15

IUPAC Name:2-(cyclohexylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(Cyclohexylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$250.00Login to see priceInquiryInquiry
100mg98%$363.00Login to see priceInquiryInquiry
250mg98%$512.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Cyclohexylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(cyclohexylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC14H23BO2
Molecular Weight234.15
SMILESCC1(C)C(C)(C)OB(C#CC2CCCCC2)O1
InChI KeyUQUSOVVXRZEHBN-UHFFFAOYSA-N
SynonymCYCLOHEXYLETHYNYLBORONIC ACID PINACOL ESTER;2-(Cyclohexylethynyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;1,3,2-Dioxaborolane, 2-(2-cyclohexylethynyl)-4,4,5,5-tetramethyl-
CAS No.1048111-37-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRATN062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRATN062 route product structure diagram
    ACRATN0621048111-37-0
Inquiry

2. ACRATN062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADNK286 route compound structure diagram
    ACADNK286931-48-6 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACRATN062 route product structure diagram
    ACRATN0621048111-37-0
Inquiry

Comments (0)